Quantitative  	Quantitative  	 NNP	B-NP
Susceptibility  	Susceptibility  	 NNP	I-NP
Mapping  	Mapping  	 NNP	O
of  	of  	 IN	O
Intracerebral  	Intracerebral  	 NNP	B-NP
Hemorrhages  	Hemorrhages  	 NNP	I-NP
at  	at  	 IN	O
Various  	Various  	 NNP	O
Stages  	Stages  	 NNP	O
To  	To  	 TO	O
investigate  	investigate  	 VB	O
the  	the  	 DT	O
magnetic  	magnetic  	 JJ	B-NP
susceptibility  	susceptibility  	 NN	I-NP
of  	of  	 IN	I-NP
intracerebral  	intracerebral  	 JJ	I-NP
hemorrhages  	hemorrhages  	 NNS	I-NP
( 	( 	 -LRB-	O
ICH 	ICH 	 NNP	B-NP
)  	)  	 -RRB-	O
at  	at  	 IN	O
various  	various  	 JJ	O
stages  	stages  	 NNS	O
by  	by  	 IN	O
applying  	applying  	 VBG	O
quantitative  	quantitative  	 JJ	B-NP
susceptibility  	susceptibility  	 JJ	I-NP
mapping  	mapping  	 NN	I-NP
( 	( 	 -LRB-	O
QSM 	QSM 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Blood  	Blood  	 NN	O
susceptibility  	susceptibility  	 NNS	O
was  	was  	 VBD	O
measured  	measured  	 VBN	O
serially  	serially  	 VBN	O
using  	using  	 VBG	O
QSM  	QSM  	 NNP	B-NP
after  	after  	 IN	O
venous  	venous  	 JJ	B-NP
blood  	blood  	 NN	I-NP
withdrawal  	withdrawal  	 NN	I-NP
from  	from  	 IN	O
healthy  	healthy  	 JJ	O
subjects 	subjects 	 NNS	B-NP
.  	.  	 .	O
Forty-two  	Forty-two  	 JJ	O
patients  	patients  	 NNS	O
who  	who  	 WP	O
provided  	provided  	 VBD	O
written  	written  	 VBN	O
consent  	consent  	 NN	O
were  	were  	 VBD	O
recruited  	recruited  	 VBN	O
in  	in  	 IN	O
this  	this  	 DT	O
Institutional  	Institutional  	 NNP	B-NP
Review  	Review  	 NNP	I-NP
Board-approved  	Board-approved  	 JJ	O
study 	study 	 NN	O
.  	.  	 .	O
Gradient  	Gradient  	 FW	B-NP
echo  	echo  	 FW	I-NP
magnetic  	magnetic  	 FW	I-NP
resonance  	resonance  	 FW	I-NP
imaging  	imaging  	 FW	O
( 	( 	 -LRB-	O
MRI 	MRI 	 NNP	B-NP
)  	)  	 -RRB-	O
data  	data  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
42  	42  	 CD	O
patients  	patients  	 NNS	O
( 	( 	 -LRB-	O
17  	17  	 CD	O
females 	females 	 NNS	O
;  	;  	 :	O
64  	64  	 CD	O
±  	±  	 CD	O
12  	12  	 CD	O
years 	years 	 NNS	O
)  	)  	 -RRB-	O
with  	with  	 IN	O
ICH  	ICH  	 NNP	B-NP
were  	were  	 VBD	O
processed  	processed  	 VBN	O
with  	with  	 IN	O
QSM 	QSM 	 NNP	B-NP
.  	.  	 .	O
The  	The  	 DT	O
susceptibilities  	susceptibilities  	 NN	O
of  	of  	 IN	O
various  	various  	 JJ	O
blood  	blood  	 NN	O
products  	products  	 NNS	O
within  	within  	 IN	O
hematomas  	hematomas  	 NN	B-NP
were  	were  	 VBD	O
measured  	measured  	 VBN	O
on  	on  	 IN	O
QSM 	QSM 	 NNP	B-NP
.  	.  	 .	O
Blood  	Blood  	 NN	O
susceptibility  	susceptibility  	 VBZ	O
continually  	continually  	 RB	O
increased  	increased  	 VBN	O
and  	and  	 CC	O
reached  	reached  	 VBD	O
a  	a  	 DT	O
plateau  	plateau  	 NN	O
96  	96  	 CD	O
hours  	hours  	 NNS	O
after  	after  	 IN	O
venous  	venous  	 JJ	B-NP
blood  	blood  	 NN	I-NP
withdrawal 	withdrawal 	 NN	I-NP
.  	.  	 .	O
Hematomas  	Hematomas  	 NNP	B-NP
at  	at  	 IN	O
all  	all  	 DT	O
stages  	stages  	 NNS	O
were  	were  	 VBD	O
consistently  	consistently  	 RB	O
hyperintense  	hyperintense  	 VBN	O
on  	on  	 IN	O
QSM 	QSM 	 NNP	B-NP
.  	.  	 .	O
Susceptibility  	Susceptibility  	 NNP	O
was  	was  	 VBD	O
0.57  	0.57  	 CD	O
±  	±  	 CD	O
0.48 	0.48 	 CD	O
,  	,  	 ,	O
1.30  	1.30  	 NNP	O
±  	±  	 NNP	O
0.33 	0.33 	 NNP	O
,  	,  	 ,	O
1.14  	1.14  	 NNP	O
±  	±  	 NNP	O
0.46 	0.46 	 NNP	O
,  	,  	 ,	O
0.40  	0.40  	 CD	O
±  	±  	 CD	O
0.13 	0.13 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
0.71  	0.71  	 CD	O
±  	±  	 CD	O
0.31  	0.31  	 CD	O
ppm  	ppm  	 NN	B-NP
for  	for  	 IN	I-NP
hyperacute 	hyperacute 	 NN	I-NP
,  	,  	 ,	O
acute 	acute 	 JJ	O
,  	,  	 ,	O
early  	early  	 JJ	O
subacute 	subacute 	 NN	B-NP
,  	,  	 ,	O
late  	late  	 JJ	O
subacute 	subacute 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
chronic  	chronic  	 JJ	B-NP
stages  	stages  	 NNS	I-NP
of  	of  	 IN	I-NP
hematomas 	hematomas 	 NN	I-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
susceptibility  	susceptibility  	 JJ	B-NP
decrease  	decrease  	 NN	I-NP
from  	from  	 IN	O
early  	early  	 JJ	O
subacute  	subacute  	 NNS	B-NP
( 	( 	 -LRB-	O
1.14  	1.14  	 FW	O
ppm 	ppm 	 FW	B-NP
)  	)  	 -RRB-	O
to  	to  	 TO	O
late  	late  	 JJ	O
subacute  	subacute  	 NNS	B-NP
( 	( 	 -LRB-	O
0.4  	0.4  	 FW	O
ppm 	ppm 	 FW	B-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
significant  	significant  	 JJ	O
( 	( 	 -LRB-	O
P    	P    	 CD	O
< 	< 	 SYM	O
0.01 	0.01 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
QSM  	QSM  	 NNP	B-NP
reveals  	reveals  	 VBZ	O
positive  	positive  	 JJ	B-NP
susceptibility  	susceptibility  	 NN	I-NP
in  	in  	 IN	O
hyperacute  	hyperacute  	 JJ	B-NP
hematomas 	hematomas 	 NN	I-NP
,  	,  	 ,	O
indicating  	indicating  	 VBG	O
that  	that  	 IN	O
even  	even  	 RB	O
at  	at  	 IN	O
their  	their  	 PRP$	O
hyperacute  	hyperacute  	 JJ	B-NP
stage 	stage 	 NN	I-NP
,  	,  	 ,	O
deoxyhemoglobin  	deoxyhemoglobin  	 NNS	B-NP
may  	may  	 MD	O
exist  	exist  	 VB	O
throughout  	throughout  	 IN	O
the  	the  	 DT	O
hematoma  	hematoma  	 JJ	B-NP
volume 	volume 	 NN	I-NP
,  	,  	 ,	O
not  	not  	 RB	O
just  	just  	 RB	O
at  	at  	 IN	O
its  	its  	 PRP$	O
rim 	rim 	 NN	O
,  	,  	 ,	O
as  	as  	 RB	O
seen  	seen  	 VBN	O
on  	on  	 IN	O
conventional  	conventional  	 JJ	B-NP
T2*  	T2*  	 CD	I-NP
imaging 	imaging 	 NN	I-NP
.  	.  	 .	O
QSM  	QSM  	 NNP	B-NP
also  	also  	 RB	O
reveals  	reveals  	 VBZ	O
a  	a  	 DT	O
reduction  	reduction  	 NN	O
of  	of  	 IN	O
susceptibility  	susceptibility  	 NN	O
from  	from  	 IN	O
early  	early  	 JJ	O
subacute  	subacute  	 NN	B-NP
to  	to  	 TO	O
late  	late  	 JJ	O
subacute  	subacute  	 JJ	B-NP
ICH 	ICH 	 NNP	I-NP
,  	,  	 ,	O
suggesting  	suggesting  	 VBG	O
that  	that  	 IN	O
methemoglobin  	methemoglobin  	 JJ	B-NP
concentration  	concentration  	 NN	I-NP
decreases  	decreases  	 NNS	I-NP
at  	at  	 IN	O
the  	the  	 DT	O
late  	late  	 JJ	O
subacute  	subacute  	 JJ	B-NP
stage 	stage 	 NN	I-NP
.  	.  	 .	O
J.  	J.  	 NNP	B-NP
Magn 	Magn 	 NNP	I-NP
.  	.  	 .	O
Reson 	Reson 	 NNP	B-NP
.  	.  	 .	O
Imaging  	Imaging  	 NNP	O
2015 	2015 	 CD	O
.  	.  	 .	O
